AAAAAA
Results:
1-11
|
Results: 11
Authors:
Agro, K
Blackhouse, G
Goeree, R
Willan, AR
Huang, JQ
Hunt, RH
O'Brien, BJ
Citation: K. Agro et al., Cost effectiveness in Canada of a multidrug prepackaged regimen (Hp-PAC (R)) for Helicobacter pylori eradication, PHARMACOECO, 19(8), 2001, pp. 831-843
Authors:
Goeree, R
Jang, D
Blackhouse, G
Chong, S
Mahony, J
Sellors, J
Foy, A
Chernesky, M
Citation: R. Goeree et al., Cost-effectiveness of screening swab or urine specimens for Chlamydia trachomatis from young Canadian women in Ontario, SEX TRA DIS, 28(12), 2001, pp. 701-709
Authors:
Sheldon, R
O'Brien, BJ
Blackhouse, G
Goeree, R
Mitchell, B
Klein, G
Roberts, RS
Gent, M
Connolly, SJ
Citation: R. Sheldon et al., Effect of clinical risk stratification on cost-effectiveness of the implantable cardioverter-defibrillator the - Canadian Implantable Defibrillator Study, CIRCULATION, 104(14), 2001, pp. 1622-1626
Authors:
O'Brien, BJ
Connolly, SJ
Goeree, R
Blackhouse, G
Willan, A
Yee, R
Roberts, RS
Gent, M
Citation: Bj. O'Brien et al., Cost-effectiveness of the implantable cardioverter-defibrillator - Resultsfrom the Canadian Implantable Defibrillator Study (CIDS), CIRCULATION, 103(10), 2001, pp. 1416-1421
Authors:
O'Brien, BJ
Willan, A
Blackhouse, G
Goeree, R
Cohen, M
Goodman, S
Citation: Bj. O'Brien et al., Will the use of low-molecular-weight heparin (enoxaparin) in patients withacute coronary syndrome save costs in Canada?, AM HEART J, 139(3), 2000, pp. 423-429
Authors:
Goeree, R
O'Brien, B
Hunt, R
Blackhouse, G
Willan, A
Watson, J
Citation: R. Goeree et al., Economic evaluation of long term management strategies for erosive oesophagitis, PHARMACOECO, 16(6), 1999, pp. 679-697
Authors:
Goeree, R
Gafni, A
Hannah, M
Myhr, T
Blackhouse, G
Citation: R. Goeree et al., Hospital selection for unit cost estimates in multicentre economic evaluations - Does the choice of hospitals make a difference?, PHARMACOECO, 15(6), 1999, pp. 561-572
Authors:
Goeree, R
O'Brien, BJ
Blackhouse, G
Agro, K
Goering, P
Citation: R. Goeree et al., The valuation of productivity costs due to premature mortality: A comparison of the human-capital and friction-cost methods for schizophrenia, CAN J PSY, 44(5), 1999, pp. 455-463
Authors:
Goeree, R
O'Brien, BJ
Goering, P
Blackhouse, G
Agro, K
Rhodes, A
Watson, J
Citation: R. Goeree et al., The economic burden of schizophrenia in Canada, CAN J PSY, 44(5), 1999, pp. 464-472
Authors:
O'Brien, B
Levine, M
Willan, A
Goeree, R
Haley, S
Blackhouse, G
Gent, M
Citation: B. O'Brien et al., Economic evaluation of outpatient treatment with low-molecular-weight heparin for proximal vein thrombosis, ARCH IN MED, 159(19), 1999, pp. 2298-2304
Authors:
O'Brien, BJ
Goeree, R
Hux, M
Iskedjian, M
Blackhouse, G
Gagnon, M
Gauthier, S
Citation: Bj. O'Brien et al., Economic evaluation of donepezil for the treatment of Alzheimer's disease in Canada, J AM GER SO, 47(5), 1999, pp. 570-578
Risultati:
1-11
|